首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   24080篇
  免费   1957篇
  国内免费   969篇
耳鼻咽喉   47篇
儿科学   510篇
妇产科学   261篇
基础医学   2754篇
口腔科学   187篇
临床医学   1856篇
内科学   4302篇
皮肤病学   158篇
神经病学   1844篇
特种医学   719篇
外科学   1857篇
综合类   3012篇
现状与发展   3篇
预防医学   1894篇
眼科学   184篇
药学   4935篇
  6篇
中国医学   1490篇
肿瘤学   987篇
  2024年   65篇
  2023年   415篇
  2022年   577篇
  2021年   1017篇
  2020年   841篇
  2019年   699篇
  2018年   742篇
  2017年   707篇
  2016年   818篇
  2015年   816篇
  2014年   1242篇
  2013年   1720篇
  2012年   1215篇
  2011年   1177篇
  2010年   993篇
  2009年   957篇
  2008年   1031篇
  2007年   1015篇
  2006年   870篇
  2005年   807篇
  2004年   694篇
  2003年   675篇
  2002年   579篇
  2001年   544篇
  2000年   508篇
  1999年   442篇
  1998年   422篇
  1997年   429篇
  1996年   379篇
  1995年   358篇
  1994年   350篇
  1993年   305篇
  1992年   318篇
  1991年   296篇
  1990年   258篇
  1989年   226篇
  1988年   229篇
  1987年   215篇
  1986年   173篇
  1985年   233篇
  1984年   263篇
  1983年   150篇
  1982年   181篇
  1981年   148篇
  1980年   141篇
  1979年   138篇
  1978年   117篇
  1977年   107篇
  1976年   105篇
  1975年   87篇
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
31.
鸡抗内毒素卵黄抗体IgY的制备   总被引:2,自引:1,他引:1  
目的:研究分别应用内毒素(LPS)、类脂A(LipidA)和大肠杆菌突变株15免疫鸡后其蛋黄中抗内毒素抗体IgY的产量、纯度、效价并筛选最佳免疫抗原。方法:分别应用内毒素(LPS)、类脂A(LipidA)和大肠杆菌J5突变株作为抗原免疫25周龄Leghom鸡,水溶法(WD)提取蛋黄中抗体IgY,双紫外光测定抗体含量,SDS-PSGE电泳检测抗体纯度,细胞酶联染色和ELISA检测抗体特异性、效价及筛选最佳免疫抗原。结果:3种抗内毒素IgY含量和效价分别为14.4mg/ml和1:12 800(J5)、10.61mg/ml和1:12 800(LPS)、9.26mg/ml和1:3200(LipidA),抗体纯度均为95%左右。结论:大肠杆菌突变株J5和内毒素(LPS)为最佳免疫抗原,免疫鸡后其蛋黄中抗内毒素抗体IgY的产量和效价最高。  相似文献   
32.
With the advent of genomics, combinatorial paradigms and high-throughput screen (HTS)-based pharmacological testing, the number of compounds flowing through the discovery pipeline is likely to escalate. At the same time, with increased knowledge of the human drug-metabolizing enzymes and the availability of in vitro absorption-metabolism (AM) models, Preclinical Drug Metabolism is poised to meet the challenges of HTS. In order to be successful, however, a rational HTS strategy (vs. serendipitous HTS) has to be employed. Such a strategy is based on automation, validation and integration of in vitroAM models and database management (AVID). A generalized strategy for rational (AVID-based) HTS in Preclinical Drug Metabolism is described briefly.  相似文献   
33.
【目的】探讨地塞米松的用药方式对孕妇糖代谢的影响。【方法】对 1999年 9月至 2 0 0 1年 1月在本院住院的15 0名不同用药方式使用地塞米松促胎儿肺成熟的孕妇进行研究 ,在用药前及用药后 18~ 2 4h抽取肘前静脉血查空腹血糖、血浆C肽 ,糖负荷后 2h血糖、血浆C肽。【结果】使用地塞米松后 ,空腹血糖值、糖负荷后 2h血糖值、空腹C肽及糖负荷后 2hC肽值较用药前高 ;用药方式对母体空腹血糖值和空腹C肽值的影响差异无统计学意义 (P >0 0 5 ) ,对母体糖负荷后 2h血糖值和糖负荷后 2hC肽值的影响差异有统计学意义 (P <0 0 5 ) ;不同糖代谢状态的受试者使用地塞米松后 ,空腹C肽值、糖负荷后 2hC肽值的改变差异有统计学意义 (P <0 0 5 )。【结论】孕妇使用地塞米松促胎儿肺成熟对母体的糖代谢均有一定程度的影响 ,用药过程中和用药后需严密监测母体血糖和胎儿宫内状况  相似文献   
34.
35.
放射性碘标记的抗人肺癌单克隆抗体2E3和6DI注入载人肺癌移植瘤裸鼠体内,静脉血放射性-时间曲线符合二室开放模型;血放射性清除半减期为3.4d,表观分布容积636ml/kg;标记抗体在体内的脱碘率为18.6%,脱落的放射性碘绝大部分从尿排出。腹腔给药吸收快,半吸收期2.08h,生物利用度89%。~(125)I标记的单克隆抗体注射后1~3d,放射性主要分布在肿瘤、血、肝、脾中,其次为肺、肾、胃、小肠;此后,血和正常组织的放射性下降,肿瘤中的放射性较高。~(131)I标记的单克隆抗体能使移植瘤清晰显像。  相似文献   
36.
目的 :探讨低胆红素血症对机体抗氧化能力和脂质过氧化的不良影响并观察VitE的干预效果。方法 :从体检健康人群中有意选择 4 5例胆红素水平偏高者 (≥ 15 μmol/L)和 4 0例胆红素水平偏低者 (≤ 9μmol/L)作为研究对象 ,抽空腹静脉血检测血清总抗氧化能力 (T -AOC) ,丙二醛 (MDA)及血浆氧化修饰低密度脂蛋白(Ox -LDL) ,并给低胆红素组每人每天口服VitE 10 0mg ,连续 2周 ,复测上述指标。结果 :与高胆红素组比 ,低胆红素组T -AOC明显降低 (P <0 .0 1) ,而MDA和Ox -LDL明显升高 (P <0 .0 5和P <0 .0 1) ,但低胆红素组补充VitE干预后 ,T -AOC显著升高 ,而MDA和Ox -LDL显著降低 (均P <0 .0 1) ,分别达到甚至超过了高胆红素组的相应水平。结论 :低胆红素血症可显著降低机体抗氧化能力 ,促进脂质过氧化 ,但这一不良影响可以通过补充VitE得到有效纠正。  相似文献   
37.
The effect of interleukin-1 on iron metabolism in rats was evaluated. Plasma iron decreased from 184 +/- 16 micrograms/dl (mean +/- SE) to 24 +/- 12 at 6 hours after interleukin-1 intramuscular administration in non-fasting rats and 109 +/- 6 micrograms/dl to 12 +/- 1 micrograms/dl in fasting rats, which was significantly lower than in control rats. Ferrokinetic studies showed a more rapid disappearance rate and lower iron turnover in interleukin-1-injected rats. The release of iron from the mononuclear phagocyte system to plasma was studied at 3 h after interleukin-1 administration. Although the percent of radioactivity in plasma of the total injected dose was 3.2 +/- 0.6% in interleukin-1, which was significantly lower than in the control rats (5.4 +/- 0.6%) at 9 h after intravenous injection of 59Fe chondroitin ferrous sulfate, there was no difference between the amount of 59Fe released from the mononuclear phagocyte system over the first 9 h in interleukin-1 and control rats. These data appear to imply that iron release is unimpaired but that, for some reason, there is an enhanced rate of clearance of the 59Fe once it has been released from the mononuclear phagocyte system into the plasma.  相似文献   
38.
It has been demonstrated that total parenteral nutrition (TPN) modulates the function of the hepatic reticuloendothelial system (RES). The objective of this study was to evaluate the impact of two different TPN lipid emulsions on the recovery of allograft RES function after orthotopic liver transplantation (OLTx). In a prospective, double-blind study, OLTx patients were randomly assigned to two treatment groups. Group I ( n=13) received a TPN regimen that included long-chain triglycerides (LCT). Group II ( n=9) received a TPN regimen that included a fat emulsion consisting of both medium-chain triglycerides (MCT) and LCT. At baseline, i.e., on days 2 or 3 after OLTx ( t1), before lipids for TPN were started, hepatic RES function was determined using the human serum albumin millimicrosphere technique (K-value, 1/min). A second measurement ( t2) was obtained after 7 days of TPN, including one of the study's two fat emulsions. The mean (+/- SD) K-value (1/min) was 0.48+/-0.16 in the LCT group and 0.55+/-0.28 in the MCT/LCT group at t1, and it improved to 0.62+/-0.21 in the LCT group and to 0.86+/-0.32 in the MCT/LCT group at t2. RES function recovery was significantly better in the MCT/LCT group ( P< or = 0.05). MCT/LCT emulsion appears to be the TPN fat emulsion of choice after OLTx as it seems to have less impact on hepatic RES recovery.  相似文献   
39.
Arsenic pollution has become increasingly severe. It occurs as the result of geological processes and different human activities. Arsenic toxicity at the respiratory level occurs mainly by inhalation of products of coal combustion. The aim of this study was to evaluate sodium arsenite (As3+) toxicity in murine alveolar macrophages (AMs) in vitro and its association with the alterations in cell metabolism.

No changes in viability, apoptosis or cell area were detected in AMs treated with As3+ concentrations up to 2 μM for 24–96 h. A marked decrease in these end-points was observed for As3+ concentrations ranging from 2.5 μM to 10 μM.

Regarding the dynamics of the endo-exocytic process triggered by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell incorporation, no variations were detected for As3+ concentrations lower than 2 μM while higher concentrations markedly modified this response.

MTT specific activity, as a measure of cell metabolic activity, was not modified irrespective of the As3+ concentration assayed. However, nitroblue tetrazolium (NBT) specific activity, as a measure of superoxide anion generation, is responsive but only to low As3+ doses.

Although this study focuses on lung macrophages, the effects of As3+ described herein may also apply to the response of macrophages residing in other organs.

Arsenite modifies the metabolic and the oxidative status of AMs in vitro. When macrophages are in an As3+ rich medium, they exhibit a reduction in respiratory burst levels and lose their intrinsic capacity to respond to toxicants.  相似文献   

40.
目的了解窒息新生儿在听觉刺激诱发脑神经活动时的脑氧合代谢和脑血流量的改变。 方法1998~2003年北京中日友好医院儿科选择窒息新生儿34例为窒息组,健康新生儿40名为对照组。使用近红外光谱仪,观察听觉刺激试验诱发的脑氧合血红蛋白\[Hb O2\]、还原血红蛋白\[Hb H\]和总血红蛋白\[Hb tot\]浓度的变化,并比较两组脑氧合代谢和脑血流量的改变。根据\[Hb O2\]、\[Hb H\]和\[Hb tot\]不同的变化,将氧合代谢曲线分为A(\[Hb O2\]、\[Hb H\]和\[Hb tot\]均增加); B(\[Hb O2\]和\[Hb tot\]增加,\[Hb H\]降低);C(\[Hb O2\]和\[Hb tot\]降低,\[Hb H\]增加)3种曲线类型。 结果窒息组中25例(25/34、73.5%)显示C型变化,对照组中28例(28/40、70.0%)显示A型变化,两组中A、C两型例数比较差异显著(P<0.05)。两组\[Hb O2\]和\[Hb tot\]数值变化幅度比较差异显著(P<0.05)。 结论窒息新生儿听觉刺激诱发相应皮层的神经活动时,显示局部脑血流量下降、氧合代谢降低,重度窒息儿更明显。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号